Xiuning Le: Looking forward to present at the European Lung Cancer Congress
Xiuning Le, Associate Professor at MD Anderson Cancer Center, shared a post on LinkedIn:
“I look forward to presenting the safety and efficacy data on Dato-DXd + osimertinib from the ORCHARD trial EGFR, Matt Hellmann, Nabil Chehab at the European Lung Cancer Congress (ELCC), ESMO – European Society for Medical Oncology in the pre-offered session next week in Paris, France.
I also look forward to:
1. The MARIPOSA overall survival presentation EGFR by Dr. James Yang Joshua, Bauml, Sanela Bilic, Mark Wildgust
2. Efficacy data on SOHO-01 cohort E HER2 by Dr. Girard Christian Rommel, Abdelali (Ali) MAJDI, Dominik Ruettinger
3. Osi + salvotinib data from the SAVANNAH study EGFR, MET by Prof. Ahn
To my pharmaceutical partners and colleagues, I deeply appreciate your unwavering dedication to improving cancer treatments. It is an honor to stand alongside with you in the fight against lung cancer. Together, we are making a difference – moving the needle and prolonging lives!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023